What is it about?
We found that Pretreatment lymphopenia, defined as absolute total lymphocyte count (TLC) before treatment intiation of more than 1000 cells/mm3, was an independent predictor of disease free survival and overall survival, after adjusting for age, stage of disease, and tumor size.
Featured Image
Read the Original
This page is a summary of: Pretreatment lymphocyte count as independent prognostic factor in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy, International Journal of Gynecology & Obstetrics, May 2022, Wiley,
DOI: 10.1002/ijgo.14229.
You can read the full text:
Contributors
The following have contributed to this page
